Reckitt Benckiser Group plc (LON:RKT – Get Free Report)’s stock price traded up 9.9% during mid-day trading on Friday . The stock traded as high as GBX 5,232 ($67.85) and last traded at GBX 5,148.73 ($66.77). 373,139,531 shares changed hands during mid-day trading, an increase of 7,325% from the average session volume of 5,025,405 shares. The stock had previously closed at GBX 4,684 ($60.74).
Wall Street Analysts Forecast Growth
RKT has been the topic of several research reports. Jefferies Financial Group restated a “hold” rating and set a GBX 4,400 ($57.06) price target on shares of Reckitt Benckiser Group in a research report on Monday, July 29th. JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group to a “neutral” rating in a research report on Friday, August 30th. Finally, Berenberg Bank lowered their price target on shares of Reckitt Benckiser Group from GBX 5,200 ($67.44) to GBX 5,177 ($67.14) and set a “hold” rating for the company in a research report on Wednesday, October 23rd.
Read Our Latest Research Report on RKT
Reckitt Benckiser Group Price Performance
Insiders Place Their Bets
In related news, insider Fiona Dawson purchased 25 shares of the stock in a transaction dated Wednesday, October 23rd. The stock was purchased at an average price of GBX 4,923 ($63.84) per share, with a total value of £1,230.75 ($1,596.10). Corporate insiders own 0.05% of the company’s stock.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- The 3 Best Blue-Chip Stocks to Buy Now
- Battle of the Retailers: Who Comes Out on Top?
- 5 Top Rated Dividend Stocks to Consider
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.